CTRI/2020/07/026820尚未招募4 期
Curcumin for COVID-19 Pre Exposure Prophylaxis: A Randomised Controlled Trail
试验速览
- 阶段
- 4 期
- 状态
- 尚未招募
- 发起方
- Rohit Walia
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •People at risk of SARS-CoV 2 infection ( healthcare professionals , attendants of COVID patients , non COVID patients admitted in hospitals or his risk groups like elderly , cardiovascular patients , diabetes , obesity )
- •Not having a previous COVID19 diagnosis
- •Not having experienced COVID19 symptoms since 30 th Jan 2020.
- •Not having taken any pre-exposure prophylaxis ( HCQ , any other medication or Ayurvedic preparation or food supplement )
- •Having a negative SARS-CoV 2 test before randomisation
排除标准
- •Any chronic infection
- •Renal failure (CrCl < 60 mL/min/1.73 m2) or need for hemodialysis
- •Known history of hypersensitivity to the study drug or any of its components
- •Immune suppressant drugs
- •Recent vaccination within 2 month
- •Primary Immunodeficiency states • Anemia
- •Thrombocytopenia
- •Co morbidities precluding survival required for duration of study follow up
研究者
相似试验
已完成
3 期
Clinical study to evaluate the effect of Ayurveda intervention as a prophylaxis for COVID-19 in Healthcare workersCTRI/2020/10/028424Ministry Of AYUSH Government of India
进行中（未招募）
1 期
PROphylaxis for paTiEnts at risk of COVID-19 infecTion - PROTECTEUCTR2020-004144-28-GBCambridge university Hosptials NHS Foundation Trust and University of Cambridge1,500
进行中（未招募）
2 期
Preventative treatment for patients at risk of COVID-19 infection (PROTECT)COVID-19 (SARS-CoV-2 infection) in dialysis, vasculitis, and kidney transplant patientsInfections and InfestationsISRCTN88057279Cambridge University Hospitals NHS Foundation Trust5,000
进行中（未招募）
2 期
A study to test a preventive drug for COVID-19 among patients with compromised immunityCTRI/2022/03/040802The George Institute New Delhi
Unknown
不适用
Evaluation of the Effect of Anatolian Propolis on Covid-19 in Healthcare ProfessionalsCovid19NCT04680819Ataturk University50